Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Olivier Meyer

Showing results (1-10 of 109) with videos related to

Pageof 11
Sort By:
Lancet (London, England)|November 25, 2003
Neonatal cutaneous lupus and congenital heart block: it's not all antibodiesOlivier Meyer
Joint Bone Spine|December 12, 2003
Evaluating inflammatory joint disease: how and when can autoantibodies help?Olivier Meyer
Bulletin De L'Academie Nationale De Medecine|February 26, 2004
[Role of TNF-alpha and cytokines in the physiopathology of rheumatoid arthritis. Therapeutic perspectives]Olivier Meyer
Joint Bone Spine|March 18, 2003
Parvovirus B19 and autoimmune diseasesOlivier Meyer
Joint Bone Spine|December 14, 2011
Interferon-alpha as a treatment target in systemic lupus erythematosusOlivier Meyer
The Journal of Rheumatology|April 3, 2012
Anti-citrullinated peptide/protein antibodies and structural prognosis of rheumatoid arthritis: quantity versus qualityOlivier Meyer
Joint Bone Spine|July 15, 2010
Anti-CRP antibodies in systemic lupus erythematosusOlivier Meyer
Joint Bone Spine|September 24, 2009
Interferons and autoimmune disordersOlivier Meyer
Annales De Medecine Interne|March 1, 2003
[Anti-SSA/Ro and anti-SSB/La antibodies. What's new?]Olivier Meyer
Joint Bone Spine|February 11, 2004
Is the celiac disease model relevant to rheumatoid arthritis?Olivier Meyer
Pageof 11

Showing results (1-10 of 109) with videos related to

Sort By:
Pageof 11
Lancet (London, England)|November 25, 2003
Neonatal cutaneous lupus and congenital heart block: it's not all antibodiesOlivier Meyer
Joint Bone Spine|December 12, 2003
Evaluating inflammatory joint disease: how and when can autoantibodies help?Olivier Meyer
Bulletin De L'Academie Nationale De Medecine|February 26, 2004
[Role of TNF-alpha and cytokines in the physiopathology of rheumatoid arthritis. Therapeutic perspectives]Olivier Meyer
Joint Bone Spine|March 18, 2003
Parvovirus B19 and autoimmune diseasesOlivier Meyer
Joint Bone Spine|December 14, 2011
Interferon-alpha as a treatment target in systemic lupus erythematosusOlivier Meyer
The Journal of Rheumatology|April 3, 2012
Anti-citrullinated peptide/protein antibodies and structural prognosis of rheumatoid arthritis: quantity versus qualityOlivier Meyer
Joint Bone Spine|July 15, 2010
Anti-CRP antibodies in systemic lupus erythematosusOlivier Meyer
Joint Bone Spine|September 24, 2009
Interferons and autoimmune disordersOlivier Meyer
Annales De Medecine Interne|March 1, 2003
[Anti-SSA/Ro and anti-SSB/La antibodies. What's new?]Olivier Meyer
Joint Bone Spine|February 11, 2004
Is the celiac disease model relevant to rheumatoid arthritis?Olivier Meyer
Pageof 11